BAAM
BLFS icon

Baker Avenue Asset Management’s BioLife Solutions BLFS Stock Holding History

Baker Avenue Asset Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-594
Closed -$8.2K – 511
2023
Q3 		$8.2K Hold
594
– – ﹤0.01% 811
2023
Q2 		$13.1K Sell
594
-414
-41% -$8.72K ﹤0.01% 704
2023
Q1 		$21.9K Hold
1,008
– – ﹤0.01% 649
2022
Q4 		$18.3K Buy
+1,008
New +$20.8K ﹤0.01% 625

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baker Avenue Asset Management's BLFS Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of BioLife Solutions (BLFS) in Q4 2023, closing a stake of 594 shares — an estimated $8.2K sold.

Baker Avenue Asset Management first reported a position in BLFS in Q4 2022 and held it in 4 quarters. The position peaked at $21.9K in Q1 2023. 140 funds tracked by Wall St. Rank hold BLFS as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining BioLife Solutions position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 594 BioLife Solutions shares in Q4 2023, an estimated $8.2K.
  • Baker Avenue Asset Management first reported a position in BioLife Solutions in Q4 2022 and held it in 4 quarters.
  • Baker Avenue Asset Management's BioLife Solutions position peaked at $21.9K in Q1 2023.
  • 140 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.